JEFFREY EUGENE SCHULTZ, MD
Medical Practice at Mission Valley Rd, San Diego, CA
License number
California G77180
Category
Medical Practice
Type
Orthopaedic Surgery
Address
Address
7485 Mission Valley Rd STE 104A, San Diego, CA 92108
Phone
(619) 291-8930
(619) 291-8491 (Fax)
(619) 291-8491 (Fax)
Personal information
See more information about JEFFREY EUGENE SCHULTZ at radaris.comName
Address
Phone
488 W Duarte Rd APT 20, Arcadia, CA 91007
480 Ferrara Ct, Pomona, CA 91766
5143 Country Ln, San Jose, CA 95129
5265 Foxborough Pt, San Diego, CA 92130
5230 Fiore Ter, San Diego, CA 92122
Professional information
Software Engineer At S2 Technologies
Position:
Software Engineer at S2 Technologies
Location:
Greater San Diego Area
Industry:
Computer Software
Work:
S2 Technologies
- Encinitas, California since Dec 2012
-
Software Engineer
SeaSpace Corporation
- Poway, California May 2012 - Dec 2012
-
Software Engineer (Contract)
Arena Pharmaceuticals
Mar 2002 - Apr 2009
-
Senior Scientist
Education:
National University 2010 - 2012
Master's degree, Computer Science University of California, Irvine 1999 - 2002
NIH Postdoctoral Fellow University of Nebraska-Lincoln 1994 - 1999
Ph.D., Chemistry North Dakota State University 1990 - 1994
B.S., Chemistry
Master's degree, Computer Science University of California, Irvine 1999 - 2002
NIH Postdoctoral Fellow University of Nebraska-Lincoln 1994 - 1999
Ph.D., Chemistry North Dakota State University 1990 - 1994
B.S., Chemistry
Skills:
Java, C++, Android, Software Engineering, Databases, Biotechnology, Drug Discovery, Chemistry, Medicinal Chemistry, Organic Chemistry
Dr. Jeffrey E Schultz, San Diego CA - MD (Doctor of Medicine)
Specialties:
Orthopedic Surgery
Address:
California Orthopaedic Institute
7485 Mission Valley Rd SUITE 104A, San Diego 92108
(619) 291-8930 (Phone), (619) 291-8491 (Fax)
7485 Mission Valley Rd SUITE 104A, San Diego 92108
(619) 291-8930 (Phone), (619) 291-8491 (Fax)
Certifications:
Orthopedic Surgery, 2000
Awards:
Healthgrades Honor Roll
Languages:
English, Spanish
Hospitals:
California Orthopaedic Institute
7485 Mission Valley Rd SUITE 104A, San Diego 92108
Scripps Mercy Hospital Chula Vista
435 H St, Chula Vista 91910
Sharp Memorial Hospital
7901 Frost St, San Diego 92123
7485 Mission Valley Rd SUITE 104A, San Diego 92108
Scripps Mercy Hospital Chula Vista
435 H St, Chula Vista 91910
Sharp Memorial Hospital
7901 Frost St, San Diego 92123
Education:
Medical School
Creighton University School Of Medicine
Graduated: 1991
Uc San Diego School Of Med
Graduated: 1992
San Francisco Orth Res Training Prg
Graduated: 1996
Creighton University School Of Medicine
Graduated: 1991
Uc San Diego School Of Med
Graduated: 1992
San Francisco Orth Res Training Prg
Graduated: 1996
Jeffrey Schultz, San Diego CA
Specialties:
Orthopaedic Surgery, Surgery, Sports Medicine
Work:
California Orthopaedic Institute Medical Associates
7485 Mission Valley Rd, San Diego, CA 92108 California Orthopaedic Institute Medical Associates Inc
8910 Clairemont Mesa Blvd, San Diego, CA 92123
7485 Mission Valley Rd, San Diego, CA 92108 California Orthopaedic Institute Medical Associates Inc
8910 Clairemont Mesa Blvd, San Diego, CA 92123
Education:
Creighton University (1991)
Jeffrey Schultz
Location:
Greater San Diego Area
Industry:
Computer Software
N-Biaryl And N-Arylheteroaryl 2-Substituted Piperazine Derivatives As Modulators Of The 5Ht2C Receptor Useful For The Treatment Of Disorders Related Thereto
US Patent:
2008025, Oct 16, 2008
Filed:
Dec 9, 2005
Appl. No.:
11/792742
Inventors:
Brian M Smith - San Diego CA, US
Vincent J. Santora - Carlsbad CA, US
Rena Hayashi - San Diego CA, US
Jason B. Ibarra - Las Vegas NV, US
Jeffrey A. Schultz - San Diego CA, US
Scott A. Estrada - La Jolla CA, US
Vincent J. Santora - Carlsbad CA, US
Rena Hayashi - San Diego CA, US
Jason B. Ibarra - Las Vegas NV, US
Jeffrey A. Schultz - San Diego CA, US
Scott A. Estrada - La Jolla CA, US
Assignee:
Arena Pharmaceuticals, Inc. - San Diego CA
International Classification:
A61K 31/496, C07D 409/10, C07D 401/10, C07D 405/10, C07D 241/04, A61P 3/00, A61P 25/00
US Classification:
51425213, 544379, 544360, 51425301, 5142541, 544403, 51425503
Abstract:
The present invention relates to certain N-biaryl and N-arylheteroaryl 2-substituted piperazine derivatives of Formula (Ia) that are modulators of the 5HT2C receptor. Accordingly, compounds of the present invention are useful for the treatment of 5HT2C receptor associated diseases or disorders, such as, obesity, Alzheimer Disease, erectile dysfunction and related disorders.
N-Biaryl And N-Arylheteroaryl Piperazine Derivatives As Modulators Of The 5Ht2C Receptor Useful For The Treatment Of Disorders Related Thereto
US Patent:
2008011, May 22, 2008
Filed:
Dec 9, 2005
Appl. No.:
11/792894
Inventors:
Brian M. Smith - San Diego CA, US
Vincent J. Santora - Carlsbad CA, US
Rena Hayashi - San Diego CA, US
Jason B. Ibarra - Las Vegas NV, US
Jeffrey A. Schultz - San Diego CA, US
Scott A. Estrada - La Jolla CA, US
Vincent J. Santora - Carlsbad CA, US
Rena Hayashi - San Diego CA, US
Jason B. Ibarra - Las Vegas NV, US
Jeffrey A. Schultz - San Diego CA, US
Scott A. Estrada - La Jolla CA, US
International Classification:
A61K 31/496, A61K 31/495, C07D 409/02, C07D 403/02, C07D 405/02
US Classification:
51425213, 51425503, 51425301, 5142541, 544360, 544372, 544390
Abstract:
The present invention relates to certain biarylz and arylheteroaryl piperazine derivatives of Formula (Ia) that are modulators of the 5HTreceptor. Accordingly, compounds of the present invention are useful for the treatment of 5HTreceptor associated diseases or disorders, such as, obesity, Alzheimer Disease, erectile dysfunction and related disorders.
Benzazepine Derivatives Useful For Treatment Of 5Ht2C Receptor Associated Diseases
US Patent:
2013017, Jul 4, 2013
Filed:
Sep 14, 2012
Appl. No.:
13/616784
Inventors:
Smith Brian - San Diego CA, US
Jeffrey Schultz - San Diego CA, US
Jeffrey Smith - San Diego CA, US
Jeffrey Schultz - San Diego CA, US
Jeffrey Smith - San Diego CA, US
International Classification:
A61K 31/55
US Classification:
51421701
Abstract:
The present invention relates to certain 1-substituted-2,3,4,5-tetrahydro-3-benzazepine derivatives of Formula (I), that are modulators of the 5HT2C receptor. Accordingly, compounds of the present invention are useful for the prophylaxis or treatment of 5HT2C receptor associated diseases, conditions or disorders, such as, obesity and related disorders.
Benzazepine Derivatives And Methods Of Prophylaxis Or Treatment Of 5Ht2C Receptor Associated Diseases
US Patent:
2008000, Jan 10, 2008
Filed:
Oct 21, 2004
Appl. No.:
10/576849
Inventors:
Brian Smith - San Diego CA, US
Charles A. Gilson III - San Diego CA, US
Jeffrey A. Schultz - San Diego CA, US
Scott A. Estrada - La Jolla CA, US
Charles A. Gilson III - San Diego CA, US
Jeffrey A. Schultz - San Diego CA, US
Scott A. Estrada - La Jolla CA, US
Assignee:
Arena Pharmaceuticals, Inc. - San Diego CA
International Classification:
A61K 31/55, A61P 15/00, A61P 25/06, A61P 25/08, A61P 25/22, A61P 25/24, A61P 25/28, A61P 25/30, A61P 3/04, C07D 223/16
US Classification:
51421701, 540594
Abstract:
The present invention relates to substituted-2,3,4,5-tetrahydro-3-benzazepine derivatives that are modulators of the 5HTreceptor. Accordingly, compounds of the present invention are useful for the prophylaxis or treatment of 5HTreceptor associated diseases, conditions or disorders, such as, obesity and related disorders.
Benzazepine Derivatives And Methods Of Prophylaxis Or Treatment Of 5Ht2C Receptor Associated Diseases
US Patent:
7704993, Apr 27, 2010
Filed:
Jun 16, 2004
Appl. No.:
10/561071
Inventors:
Brian Smith - San Diego CA, US
Jeffrey Schultz - San Diego CA, US
Jeffrey Smith - San Diego CA, US
Jeffrey Schultz - San Diego CA, US
Jeffrey Smith - San Diego CA, US
Assignee:
Arena Pharmaceuticals, Inc. - San Diego CA
International Classification:
A61P 25/00, A61K 31/55, C07D 223/16
US Classification:
51421701, 540594
Abstract:
The present invention relates to certain 1-substituted-2,3,4,5-tetrahydro-3-benzazepine derivatives of Formula (I), that are modulators of the 5HT2C receptor. Accordingly, compounds of the present invention are useful for the prophylaxis or treatment of 5HT2C receptor associated diseases, conditions or disorders, such as, obesity and related disorders.
Benzazepine Derivatives And Methods Of Prophylaxis Or Treatment Of 5Ht2C Receptor Associated Diseases
US Patent:
2007027, Nov 29, 2007
Filed:
Oct 21, 2004
Appl. No.:
10/573196
Inventors:
Brian Smith - San Diego CA, US
Jeffrey Schultz - San Diego CA, US
Charles Gilson III - San Diego CA, US
Scott Estrada - La Jolla CA, US
Jeffrey Schultz - San Diego CA, US
Charles Gilson III - San Diego CA, US
Scott Estrada - La Jolla CA, US
Assignee:
Arena Pharmaceuticals, Inc. - San Diego CA
International Classification:
A61K 31/55, A61P 43/00, C07D 223/16
US Classification:
514217020, 540595000
Abstract:
The present invention relates to substituted-2,3,4,5-tetrahydro-3-benzazepine derivatives that are modulators of the 5HTreceptor. Accordingly, compounds of the present invention are useful for the prophylaxis treatment of 5HTreceptor associated diseases, conditions or disorders, such as, obesity and related disorders.